​

Skye Bioscience (SKYE) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

SKYE Stock Forecast

Skye Bioscience (SKYE) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $2.00, with a high of $2.00 and a low of $2.00. This represents a 32.45% increase from the last price of $1.51.

$1 $2 $3 $4 $5 $6 $7 $8 $9 High: $2 Avg: $2 Low: $2 Last Closed Price: $1.51

SKYE Stock Rating

Skye Bioscience stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

SKYE Price Target Upside V Benchmarks

TypeNameUpside
StockSkye Bioscience32.45%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts122
Avg Price Target$2.00$2.00$2.00
Last Closing Price$1.51$1.51$1.51
Upside/Downside32.45%32.45%32.45%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 25332--8
Oct, 2535---8
Sep, 2525---7
Aug, 2534---7
Jul, 2534---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 06, 2025Craig-Hallum$2.00$1.886.38%32.45%
Oct 06, 2025Cantor Fitzgerald$2.00$2.12-5.66%32.45%
Sep 10, 2024Jonathan WollebenJMP Securities$15.00$6.35136.22%893.38%
Aug 26, 2024Albert LoweCraig-Hallum$18.00$5.97201.51%1092.05%
Jun 10, 2024Jay OlsonOppenheimer$21.00$9.98110.42%1290.73%
May 23, 2024Kristen KluskaCantor Fitzgerald$21.00$11.9875.29%1290.73%
Apr 11, 2024Jay OlsonOppenheimer$25.00$12.6997.01%1555.63%
Mar 14, 2024Edward TenthoffPiper Sandler$20.00$12.9055.04%1224.50%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 06, 2025Craig-HallumBuyHolddowngrade
Oct 06, 2025Cantor FitzgeraldOverweightNeutraldowngrade
Sep 30, 2025H.C. WainwrightBuyinitialise
Aug 14, 2025Evercore ISIOutperforminitialise
Feb 27, 2025William BlairOutperforminitialise
Sep 30, 2024ScotiabankOutperforminitialise
Sep 20, 2024Cantor FitzgeraldOverweightOverweighthold
Sep 10, 2024JMP SecuritiesOutperforminitialise
Aug 26, 2024Craig-HallumBuyBuyhold
Jul 09, 2024Craig-HallumBuyinitialise

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-5.37$-0.73---
Avg Forecast$-5.43$-0.64$-1.18$-1.44$-1.90
High Forecast$-5.43$-0.50$-1.08$-1.11$-1.40
Low Forecast$-5.43$-0.84$-1.33$-1.69$-2.59
Surprise %-1.10%14.06%---

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported-----
Avg Forecast-----
High Forecast-----
Low Forecast-----
Surprise %-----

Net Income Forecast

$-95M $-79M $-63M $-47M $-31M $-15M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-37.65M$-26.57M---
Avg Forecast$-38.04M$-24.45M$-43.05M$-55.08M$-75.29M
High Forecast$-38.04M$-18.24M$-39.41M$-40.50M$-51.08M
Low Forecast$-38.04M$-30.65M$-48.53M$-61.66M$-94.50M
Surprise %-1.05%8.67%---

SKYE Forecast FAQ

Is Skye Bioscience stock a buy?

Skye Bioscience stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Skye Bioscience is a favorable investment for most analysts.

What is Skye Bioscience's price target?

Skye Bioscience's price target, set by 5 Wall Street analysts, averages $2 over the next 12 months. The price target range spans from $2 at the low end to $2 at the high end, suggesting a potential 32.45% change from the previous closing price of $1.51.

How does Skye Bioscience stock forecast compare to its benchmarks?

Skye Bioscience's stock forecast shows a 32.45% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Skye Bioscience over the past three months?

  • November 2025: 37.50% Strong Buy, 37.50% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 37.50% Strong Buy, 62.50% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 28.57% Strong Buy, 71.43% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Skye Bioscience’s EPS forecast?

Skye Bioscience's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.18, marking a 61.64% increase from the reported $-0.73 in 2024. Estimates for the following years are $-1.44 in 2026, and $-1.9 in 2027.

What is Skye Bioscience’s revenue forecast?

Skye Bioscience's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, and $0 for 2027.

What is Skye Bioscience’s net income forecast?

Skye Bioscience's net income forecast for the fiscal year ending in December 2025 stands at $-43.055M, representing an 62.06% increase from the reported $-26.567M in 2024. Projections indicate $-55.075M in 2026, and $-75.289M in 2027.